OQROSign up free
Politician trade (House)

Amgen (AMGN): Rep. David J. Taylor (OH02) disclosed a sale $1K–$15K

Rep. David J. Taylor (OH02) disclosed a sale of Amgen in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
9 days
Disclosure lag
Traded
Nov 3, 2026
Disclosed
Nov 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 26, 2026Congress · 1 personMembers of Congress: 2 sales
  2. Sep 22, 2026CongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
  3. Oct 9, 2026FDAFDA drug approval: Repatha
  4. Oct 22, 2026FDAFDA drug approval: Pavblu
  5. Oct 26, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 26, 2026, the Board of Directors (the “Board”) of Amgen Inc. (the “Company”) appointed David W. Gibbs as a director of the Company, effective immediately.”
  6. Nov 3, 2026 · this disclosureCongressDisclosed sale of AMGN — reported range $1,001 - $15,000

What came next

  1. Nov 3, 2026Company filing · Form 8-K · ResultsReported its results
  2. Nov 3, 2026CongressDisclosed sale of AMGN — reported range $1,001 - $15,000
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Amgen

For Amgen, OQRO holds 6 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AMGN page.

Other recent filings by Rep. David J. Taylor (OH02)

The full history of Rep. David J. Taylor (OH02) is on the profile page.

How this filing works

Explore the data

Other disclosures at Amgen

Everything OQRO holds on this company is on its AMGN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data